Phase 2 Study of Dabrafenib Plus Trametinib in Patients With BRAF V600E-Mutant Metastatic NSCLC: Updated 5-Year Survival Rates and Genomic Analysis
| Autor: | Planchard, David, Besse, Benjamin, Groen, Harry J.M., Hashemi, Sayed M.S., Mazieres, Julien, Kim, Tae Min, Quoix, Elisabeth, Souquet, Pierre-Jean, Barlesi, Fabrice, Baik, Christina, Villaruz, Liza C., Kelly, Ronan J., Zhang, Shirong, Tan, Monique, Gasal, Eduard, Santarpia, Libero, Johnson, Bruce E. |
|---|---|
| Zdroj: | In Journal of Thoracic Oncology January 2022 17(1):103-115 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|